Renal Replacement Therapy in Autosomal Dominant Polycystic Kidney Disease
作者:
Satwant Singh,
Sundaram Hariharan,
期刊:
Nephron
(Karger Available online 1991)
卷期:
Volume 57,
issue 1
页码: 40-44
ISSN:1660-8151
年代: 1991
DOI:10.1159/000186213
出版商: S. Karger AG
关键词: Autosomal dominant polycystic kidney disease;Renal replacement therapy;Morbidity;Mortality;Hemodialysis;Peritoneal dialysis;Renal transplantation
数据来源: Karger
摘要:
Autosomal dominant polycystic kidney disease (ADPKD) accounted for 4.6% of our end-stage renal disease (ESRD) population. Initial ESRD therapy consisted of hemodialysis in 78% and continuous ambulatory peritoneal dialysis in 22% with significant intertherapy transfers. Half of these patients underwent one or more renal transplantations. Infections, primarily related to ADPKD or ESRD therapy, were the leading cause of morbidity in these patients. 3% of total time on ESRD therapy was spent in hospital, half of it due to problems related to ADPKD and ESRD therapy. Overall mortality and morbidity (as measured by hospitalization rates) in ADPKD patients were similar to those in a non diabetic ESRD population.
点击下载:
PDF
(943KB)
返 回